Luye Pharma Group Ltd.

ACTIVE

c/o Codan Services Limited, 香港, 香港特别行政区, Chinawww.luye.cnPublic5,270 employeesEstablished: 2014-04-28

Clinical Trials

13 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

2014

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

76.0%

Phase 3

16.0%

Phase 2

6.7%

Phase 4

1.3%

Trial Status Distribution

Active, not recruiting

4.0%

Completed

61.3%

Enrolling By Invitation

2.7%

Not yet recruiting

10.7%

Recruiting

8.0%

Unknown

13.3%

Clinical Trials

Trials sponsored by this organization (75)

Mass Balance Study of [14C] LPM3770164 in Healthy Participants

Phase 1

Not yet recruiting

interventional

Apr 20268 participants

A Study of LY03015 in Healthy Chinese and Caucasian Adult Subjects

Phase 1

Completed

interventional

Apr 202624 participants

LPM6690176 in Combination With Chemotherapy and Bevacizumab in Metastatic Colorectal Cancer Patients With RAS Mutation

Phase 1

Not yet recruiting

interventional

Mar 202699 participants

A Phase 2 Study to Evaluate the Efficacy and Safety of LY03020 in Acutely Psychotic Participants With Schizophrenia

Phase 2

Not yet recruiting

interventional

Mar 2026160 participants

To Evaluate the Safety, Tolerability, Pharmacokinetic Characteristics and Food Effects of LY03021 in Healthy Chinese Subjects

Phase 1

Enrolling By Invitation

interventional

Oct 202598 participants

A Phase 1 MAD Study to Evaluate the Safety and Tolerability of LY03020

Phase 1

Recruiting

interventional

Aug 202540 participants

A Food Effect Study of LY03020 in Healthy Subjects

Phase 1

Active, not recruiting

interventional

Jul 202516 participants

A Phase 1, MAD Study to Evaluate the Safety, Tolerability and Pharmacokinetics of LY03017

Phase 1

Not yet recruiting

interventional

May 202540 participants

Page 1 of 10

Approvals

No approval data available

News

No news articles found

Back to Organizations